Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Scientists Help Put Bed Bugs to Bed – Forever

December 29, 2014 By AxoGen, Inc.

The world owes a debt of gratitude to Simon Fraser University biologist Regine Gries. Her arms have provided a blood meal for more than a thousand bedbugs each week for five years while she and her husband, biology professor Gerhard Gries, searched for a way to conquer the global bedbug epidemic. 

Working with SFU chemist Robert Britton and a team of students, they have finally found the solution–a set of chemical attractants, or pheromones, that lure the bedbugs into traps, and keep them there.

This month, after a series of successful trials in bedbug-infested apartments in Metro Vancouver, they have published their research, Bedbug aggregation pheromone finally identified, in Angewandte Chemie, a leading general chemistry journal.

They’re working with Victoria-based Contech Enterprises Inc. to develop the first effective and affordable bait and trap for detecting and monitoring bedbug infestations. They expect it to be commercially available next year.

“The biggest challenge in dealing with bedbugs is to detect the infestation at an early stage,” says Gerhard, who holds an NSERC-Industrial Research Chair in Multimodal Animal Communication Ecology.

“This trap will help landlords, tenants, and pest-control professionals determine whether premises have a bedbug problem, so that they can treat it quickly. It will also be useful for monitoring the treatment’s effectiveness.”

It’s a solution the world has been waiting for.

Over the last two decades the common bedbug (Cimex lectularius), once thought eradicated in industrialized countries, has reappeared as a global scourge. These nasty insects are infesting not just low-income housing but also expensive hotels and apartments, and public venues such as stores, movie theatres, libraries and even public transit.

And while these blood-sucking pests were previously not considered a carrier of disease, scientists have recently discovered they can transmit the pathogen that causes Chagas disease, which is prevalent in Central and South America. Yet until now, tools for detecting and monitoring these pests have been expensive and technically challenging to use.

Backgrounder: The research story–180,000 bedbug bites later

The Gries’ began their research eight years ago when Gerhard, who is internationally renowned for his pioneering work in chemical and bioacoustic communication between insects, began searching for pheromones that could lure and trap bedbugs.

Regine worked with him, running all of the lab and field experiments and, just as importantly, enduring 180,000 bedbug bites in order to feed the large bedbug colony required for their research. She became the unintentional “host” because, unlike Gerhard, she is immune to the bites, suffering only a slight rash instead of the ferocious itching and swelling most people suffer.

The Gries’ and their students initially found a pheromone blend that attracted bedbugs in lab experiments, but not in bedbug-infested apartments. “We realized that a highly unusual component must be missing–one that we couldn’t find using our regular gas chromatographic and mass spectrometric tools,” says Gerhard.

That’s when they teamed up with Britton, an expert in isolating and solving the structure of natural products, and then synthesizing them in the lab. He used SFU’s state-of-the-art NMR spectrometers to study the infinitesimal amounts of chemicals Regine had isolated from shed bedbug skin, looking for the chemical clues as to why the bedbugs find the presence of skin so appealing in a shelter.

It was like looking for a needle in a haystack.

After two years of frustrating false leads, Britton, his students and the Gries duo finally discovered that histamine, a molecule with unusual properties that eluded identification through traditional methods, signals “safe shelter” to bedbugs. Importantly, once in contact with the histamine, the bedbugs stay put whether or not they have recently fed on a human host.

Yet, to everyone’s disbelief, neither histamine alone nor in combination with the previously identified pheromone components effectively attracted and trapped bedbugs in infested apartments. So Regine began analyzing airborne volatile compounds from bedbug faeces as an alternate source of the missing components.

Five months and 35 experiments later, she had found three new volatiles that had never before been reported for bedbugs. These three components, together with two components from their earlier research and, of course, histamine, became the highly effective lure they were seeking.

Their research isn’t over yet, however. They continue to work with Contech Enterprises to finalize development of the commercial lure–which means Regine is still feeding the bedbugs every week. “I’m not too thrilled about this,” admits Regine, “but knowing how much this technology will benefit so many people, it’s all worth it.”

Related Articles Read More >

A photo showing the Dualto Energy System's modular design with two generators stacked for two users at a time.
What J&J MedTech’s new Dualto says about the OR of the future — and Ottava
An illustration showing the Edwards Lifesciences Sapien M3 transcatheter mitral valve replacement (TMVR) system's valve being placed in the heart. [Image courtesy of Edwards Lifesciences]
Q&A with Darshin Patel, who led the Edwards Lifesciences Sapien M3 TMVR system’s development
A photo of nitinol, a nickel-titanium alloy used for medical devices such as stents, heart valves, catheters and orthopedics.
What is nitinol and where is it used?
An illustration showing the The Focal One Robotic HIFU system ablating a tumor with ultrasound energy.
Cleveland Clinic reports world’s first transcontinental robot-assisted focal therapy procedure for prostate cancer
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe